Notably, the alveolar epithelial type II cells (AECII) are responsible for approximately 83% of ACE2 expression, emphasizing the pivotal role of these cells as the primary target for SARS-CoV-2 viral infections [42]. The gene discussed is ACE2; the disease is viral infectious disease.